CONMED CORP (CNMD) Stock Fundamental Analysis
USA - NYSE:CNMD - US2074101013 - Common Stock
47.76 USD
-0.5 (-1.04%)
47.76 USD
0 (0%)
Overall CNMD gets a fundamental rating of 6 out of 10. We evaluated CNMD against 189 industry peers in the Health Care Equipment & Supplies industry. CNMD has an excellent profitability rating, but there are some minor concerns on its financial health. CNMD may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year CNMD was profitable.
In the past year CNMD had a positive cash flow from operations.
Of the past 5 years CNMD 4 years were profitable.
Each year in the past 5 years CNMD had a positive operating cash flow.
1.2 Ratios
CNMD's Return On Assets of 4.73% is amongst the best of the industry. CNMD outperforms 81.05% of its industry peers.
CNMD's Return On Equity of 10.99% is amongst the best of the industry. CNMD outperforms 86.84% of its industry peers.
The Return On Invested Capital of CNMD (7.55%) is better than 83.68% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CNMD is below the industry average of 9.00%.
The 3 year average ROIC (5.34%) for CNMD is below the current ROIC(7.55%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROIC | 7.55% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
CNMD has a Profit Margin of 8.31%. This is amongst the best in the industry. CNMD outperforms 81.05% of its industry peers.
CNMD's Profit Margin has improved in the last couple of years.
CNMD has a Operating Margin of 14.38%. This is amongst the best in the industry. CNMD outperforms 83.16% of its industry peers.
In the last couple of years the Operating Margin of CNMD has grown nicely.
CNMD has a Gross Margin of 56.05%. This is comparable to the rest of the industry: CNMD outperforms 52.11% of its industry peers.
CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNMD is still creating some value.
Compared to 1 year ago, CNMD has more shares outstanding
The number of shares outstanding for CNMD has been increased compared to 5 years ago.
The debt/assets ratio for CNMD has been reduced compared to a year ago.
2.2 Solvency
CNMD has an Altman-Z score of 2.04. This is not the best score and indicates that CNMD is in the grey zone with still only limited risk for bankruptcy at the moment.
CNMD has a Altman-Z score (2.04) which is comparable to the rest of the industry.
CNMD has a debt to FCF ratio of 5.95. This is a neutral value as CNMD would need 5.95 years to pay back of all of its debts.
The Debt to FCF ratio of CNMD (5.95) is better than 78.42% of its industry peers.
A Debt/Equity ratio of 0.88 indicates that CNMD is somewhat dependend on debt financing.
The Debt to Equity ratio of CNMD (0.88) is worse than 74.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Altman-Z | 2.04 |
ROIC/WACC1.18
WACC6.38%
2.3 Liquidity
A Current Ratio of 2.23 indicates that CNMD has no problem at all paying its short term obligations.
CNMD's Current ratio of 2.23 is in line compared to the rest of the industry. CNMD outperforms 41.05% of its industry peers.
A Quick Ratio of 1.00 indicates that CNMD should not have too much problems paying its short term obligations.
CNMD's Quick ratio of 1.00 is on the low side compared to the rest of the industry. CNMD is outperformed by 75.79% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.38%, which is quite impressive.
Measured over the past years, CNMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.44% on average per year.
Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 3.94% in the last year.
Measured over the past years, CNMD shows a small growth in Revenue. The Revenue has been growing by 6.47% on average per year.
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
3.2 Future
Based on estimates for the next years, CNMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.42% on average per year.
CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.42% yearly.
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.64, the valuation of CNMD can be described as very reasonable.
93.16% of the companies in the same industry are more expensive than CNMD, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.89. CNMD is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 9.82, the valuation of CNMD can be described as reasonable.
CNMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 94.21% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.99. CNMD is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 9.82 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CNMD is valued cheaply inside the industry as 92.63% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CNMD is valued cheaply inside the industry as 96.32% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.97 | ||
| EV/EBITDA | 8.82 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)1.11
PEG (5Y)1.13
EPS Next 2Y8.14%
EPS Next 3Y9.42%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.66%.
Compared to an average industry Dividend Yield of 1.79, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.26% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.31, CNMD is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.66% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
CNMD pays out 22.42% of its income as dividend. This is a sustainable payout ratio.
DP22.42%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
47.76
-0.5 (-1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.95%
Inst Owner Change1.26%
Ins Owners0.27%
Ins Owner Change-0.53%
Market Cap1.48B
Revenue(TTM)1.33B
Net Income(TTM)110.20M
Analysts73.33
Price Target62.99 (31.89%)
Short Float %6.73%
Short Ratio5.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.66% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP22.42%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)0.37%
Max EPS beat(2)14.78%
EPS beat(4)4
Avg EPS beat(4)7%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.79%
EPS beat(12)10
Avg EPS beat(12)-0.43%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)1
Avg Revenue beat(2)-0.12%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)-10.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.71%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.64 | ||
| Fwd PE | 9.82 | ||
| P/S | 1.11 | ||
| P/FCF | 9.97 | ||
| P/OCF | 8.95 | ||
| P/B | 1.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.82 |
EPS(TTM)4.49
EY9.4%
EPS(NY)4.87
Fwd EY10.19%
FCF(TTM)4.79
FCFY10.03%
OCF(TTM)5.34
OCFY11.18%
SpS42.85
BVpS32.4
TBVpS-13.11
PEG (NY)1.11
PEG (5Y)1.13
Graham Number57.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROCE | 9.38% | ||
| ROIC | 7.55% | ||
| ROICexc | 7.68% | ||
| ROICexgc | 25.98% | ||
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% | ||
| FCFM | 11.18% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.62%
ROICexgc growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 23.31% | ||
| Cap/Sales | 1.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.68% | ||
| Profit Quality | 134.53% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.04 |
F-Score7
WACC6.38%
ROIC/WACC1.18
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y11.97%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year45.54%
EBIT Next 3Y17.93%
EBIT Next 5YN/A
FCF growth 1Y832.34%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y345.31%
OCF growth 3Y14.3%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
What is the valuation status of CONMED CORP (CNMD) stock?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 8 / 10.
What is the valuation of CONMED CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 10.64 and the Price/Book (PB) ratio is 1.47.
How financially healthy is CONMED CORP?
The financial health rating of CONMED CORP (CNMD) is 4 / 10.